Director Robert Mylod sold $1M of BKNG shares at $200, reducing his directly held stake by 23.8% just 2.3% below the 90-day high. This appears to be routine diversification given his history of consistent selling and lack of supporting cluster buys from other insiders.

Where it could go — Our 5-6 conviction sells: 50% beat SPY at 30d with avg -0.4% vs SPY; watch $204.61 as resistance, $170.31 as support.

Director Vanessa Wittman sold $216K of BKNG shares at $192, reducing her directly held stake by 6.4% while the stock traded just 4% below its 90-day high. This appears to be routine diversification rather than a strong bearish signal, as she has executed six similar-sized sales over the past year with no other insiders buying.

Where it could go — Our 5-6 conviction sells: 50% beat SPY at 30d (n=289, avg -0.4% vs SPY); analyst mean target implies upside from current levels.

Executive VP & General Counsel Peter J. Millones sold $3.3M worth of BKNG shares at $162.96, reducing his stake by 4.2% at a price just 8.5% above the 90-day low. As a first-time seller liquidating a meaningful portion of his position near recent lows, this action contradicts the overwhelmingly positive analyst sentiment and raises questions about internal confidence. Bear: a decisive break below the recent $150.14 low could signal deeper fundamental concerns.

Where it could go — Broad base rate for similar isolated officer sells is 0.0% positive at 90d; bear breaks $150.14.